Pyridoxamine

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Pyridoxamine
DrugBank Accession Number
DB11673
Background

Pyridoxamine has been used in trials studying the treatment of Kidney Stones.

Type
Small Molecule
Groups
Investigational
Structure
Thumb
Weight
Average: 168.1931
Monoisotopic: 168.089877638
Chemical Formula
C8H12N2O2
Synonyms
Not Available

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
Pyridoxamine hydrochloride58WN04G9K95103-96-8PFIPZKASKUWLHH-UHFFFAOYSA-N
Pyridoxamine phosphateQWW7V2981484878-64-8XYFGQXNREWPENX-UHFFFAOYSA-N

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as pyridoxamine 5'-phosphates. These are heterocyclic aromatic compounds containing a pyridoxamine that carries a phosphate group at the 5'-position.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Pyridines and derivatives
Sub Class
Pyridoxamines
Direct Parent
Pyridoxamine 5'-phosphates
Alternative Parents
Methylpyridines / Hydroxypyridines / Aralkylamines / Heteroaromatic compounds / Azacyclic compounds / Primary alcohols / Organopnictogen compounds / Monoalkylamines / Hydrocarbon derivatives / Aromatic alcohols
Substituents
Alcohol / Amine / Aralkylamine / Aromatic alcohol / Aromatic heteromonocyclic compound / Azacycle / Heteroaromatic compound / Hydrocarbon derivative / Hydroxypyridine / Methylpyridine
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
monohydroxypyridine, aminoalkylpyridine, vitamin B6, hydroxymethylpyridine (CHEBI:16410) / Water-soluble vitamins (C00534)
Affected organisms
Not Available

Chemical Identifiers

UNII
6466NM3W93
CAS number
85-87-0
InChI Key
NHZMQXZHNVQTQA-UHFFFAOYSA-N
InChI
InChI=1S/C8H12N2O2/c1-5-8(12)7(2-9)6(4-11)3-10-5/h3,11-12H,2,4,9H2,1H3
IUPAC Name
4-(aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol
SMILES
CC1=C(O)C(CN)=C(CO)C=N1

References

General References
Not Available
Human Metabolome Database
HMDB0001431
KEGG Compound
C00534
PubChem Compound
1052
PubChem Substance
347828041
ChemSpider
1023
ChEBI
16410
ChEMBL
CHEMBL593019
ZINC
ZINC000034926229
PDBe Ligand
PXM
Wikipedia
Pyridoxamine
PDB Entries
1rft / 2z9v / 4ha6 / 6k90

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2WithdrawnTreatmentKidney Stones1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility29.0 mg/mLALOGPS
logP-1.2ALOGPS
logP-1.6ChemAxon
logS-0.76ALOGPS
pKa (Strongest Acidic)7.82ChemAxon
pKa (Strongest Basic)9.82ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area79.37 Å2ChemAxon
Rotatable Bond Count2ChemAxon
Refractivity45.76 m3·mol-1ChemAxon
Polarizability17.53 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-001j-0590000000-a4bf9fe291241c903e3d
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (3 TMS)GC-MSsplash10-00di-9350000000-3b1415672e7ab22d5e64
GC-MS Spectrum - GC-MS (3 TMS)GC-MSsplash10-001i-1490000000-7214a8743cbe260268ce
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-001j-0590000000-a4bf9fe291241c903e3d
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-00di-9350000000-3b1415672e7ab22d5e64
GC-MS Spectrum - GC-MSGC-MSsplash10-001i-1490000000-7214a8743cbe260268ce
MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated)LC-MS/MSsplash10-014i-0900000000-4ca97fcd886d80336a5c
MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated)LC-MS/MSsplash10-001i-1900000000-499c48bce709456248bc
MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated)LC-MS/MSsplash10-0059-9200000000-aee74b4498be7c8cea6f
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, NegativeLC-MS/MSsplash10-014i-0900000000-f1da14360063a04c11b4
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, NegativeLC-MS/MSsplash10-014r-0900000000-f5aea0fa928eb266a79d
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, NegativeLC-MS/MSsplash10-00di-0900000000-bebad702dbdba57d61fa
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, NegativeLC-MS/MSsplash10-05fr-0900000000-7322846ca1b4d95b5b16
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, NegativeLC-MS/MSsplash10-0ab9-2900000000-da43b1a049d349d91831
LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , PositiveLC-MS/MSsplash10-014i-0900000000-6b5f1d606df91ae52eb4
LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) 30V, PositiveLC-MS/MSsplash10-0gb9-0900000000-d5a16a4cdc19453ae9c7
LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , NegativeLC-MS/MSsplash10-01b9-0900000000-3a1f853ce36bb047e05f
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0uxr-0900000000-a1db882596b08c2987a7
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0ue9-0900000000-b0f20e8503b963c8a31f
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-001i-3900000000-b41efa32a572817ef0c9
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-014i-0900000000-cd842fcc776d552a0f07
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-052r-0900000000-ae76358c88e1a1cf17dc
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0596-9600000000-eeec53c65ada2bc944b0
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-014i-0900000000-f1da14360063a04c11b4
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-014r-0900000000-f5aea0fa928eb266a79d
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-00di-0900000000-c7a2dec0f7555dcc5ef7
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-05fr-0900000000-fe3f1f78fad714162a1c
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0ab9-2900000000-da43b1a049d349d91831
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-01b9-0900000000-f0cc74a9651686c1610c
MS/MS Spectrum - , negativeLC-MS/MSsplash10-014i-0900000000-9303a95b8f51c5ce6c22
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-014i-0900000000-6b5f1d606df91ae52eb4
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0gb9-0900000000-d5a16a4cdc19453ae9c7
MS/MS Spectrum - , positiveLC-MS/MSsplash10-0udi-0900000000-e7c1a5c0a15d2286fd9e
1H NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
[1H,1H] 2D NMR Spectrum2D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable

Drug created on October 20, 2016 20:38 / Updated on June 12, 2020 16:53